Research Infosource Inc., a Canadian research, consulting and publishing firm, has released its annual ranking of Canada’s top 40 research hospitals. With $170 million in combined research funding for the 2023-2024 financial year, the Vancouver Coastal Health Research Institute (VCHRI) and Providence Research have once again ranked among the top hospital-based research institutes nationwide.
Master Protocol of Two Independent, Randomized, Double-blind Phase 3 Studies Comparing Efficacy and Safety of Frexalimab (SAR441344) to Teriflunomide in Adult Participants With Relapsing Forms of Multiple Sclerosis
New Vancouver Coastal Health Research Institute (VCHRI)-led research reveals an alarming number of people suffering spinal cord injuries while mountain biking, often leading to permanent and life-altering paralysis.
With more than 18 per cent of people aged 65 and older, Canada’s aging population is in need of innovative, research-based approaches to slow brain decline and better the quality of life of older adults.
Approximately 300,000 Canadians live with type 1 diabetes, an autoimmune disorder with no known cure. Type 1 diabetes can pose serious challenges, but ongoing research is improving the quality of life for those with this chronic condition. Endocrinologist Dr. Breay Paty discusses the effects of low and high blood sugar, as well as science-backed management strategies and emerging biological treatments for type 1 diabetes.
A first-of-its-kind study led by Vancouver Coastal Health Research Institute researcher Dr. Helen Tremlett and Dr. Ali Mirza, along with an international team of researchers, has identified statistically significant links between diet, gut microbiota and multiple sclerosis (MS). Published in Nature, Communications Medicine, researchers found that the consumption of a Mediterranean diet was associated with lower odds of pediatric-onset MS.
Vancouver Coastal Health Research Institute researchers Drs. Lynn Raymond and Shernaz Bamji have been re-appointed as co-directors of the Djavad Mowafaghian Centre for Brain Health, which celebrated 10 years of excellence in research, education and clinical care in 2024.
EVOID-AS: An Adaptive 2/3 Multicentre, Double-blind, Placebo-controlled, Randomized, Parallel 3 Arm Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis
Surgeons need a detailed view of tissues when performing complex, non-invasive procedures using robot assistance, making advances in tissue imaging computer software essential to minimise errors. The Surgical Tattoos in Infrared (STIR) technology designed by Vancouver Coastal Health Research Institute researcher Dr. Tim Salcudean and Dr.
Conducted in collaboration with members of the community, new research has linked an education program for school-aged adolescents to improved knowledge and attitudes about menstrual health and endometriosis, which affects 10 per cent of women and girls of reproductive age globally.
